Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Ustekinumab in the Treatment of Anti-TNFα Naive Participants With Active Radiographic Axial Spondyloarthritis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating ustekinumab for active radiographic axial spondyloarthritis in anti-TNFα naive patients was terminated, with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Axial Spondyloarthritis

Drugs mentioned

• USTEKINUMAB (USTEKINUMAB)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Axial Spondyloarthritis | Phase 3 | Status: TERMINATED | Results posted: 2018-04-23